These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21267561)

  • 1. Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR.
    Bartolozzi C; Battaglia V; Bozzi E
    Abdom Imaging; 2011 Jun; 36(3):290-9. PubMed ID: 21267561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCC diagnosis with liver-specific MRI--close to histopathology.
    Bartolozzi C; Battaglia V; Bozzi E
    Dig Dis; 2009; 27(2):125-30. PubMed ID: 19546550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to differentiate liver lesions in cirrhosis.
    Bartolozzi C; Crocetti L; Della Pina MC
    JBR-BTR; 2007; 90(6):475-81. PubMed ID: 18376759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
    Willatt JM; Hussain HK; Adusumilli S; Marrero JA
    Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
    Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
    Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guest editor's introduction: hepatocellular nodules in liver cirrhosis: imaging update 2011.
    Choi BI
    Abdom Imaging; 2011 Jun; 36(3):230-1. PubMed ID: 21267564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules.
    Lupescu IG; Capsa RA; Gheorghe L; Herlea V; Georgescu SA
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):341-6. PubMed ID: 18836633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of echography, computerized tomography and magnetic resonance imaging in the diagnosis of hepatocellular carcinoma in cirrhotic patients].
    Dalla Palma L; Pozzi-Mucelli RS; Bazzocchi M; Pozzi-Mucelli R; Ferrara P
    Radiol Med; 1991; 81(1-2):8-15. PubMed ID: 1848720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural course of small nodular lesions with intranodular preserved portal supply in cirrhotic liver.
    Fukunaga T; Kudo M; Tochio H; Okabe Y; Orino A
    Oncology; 2007; 72 Suppl 1():24-9. PubMed ID: 18087179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of hepatocellular carcinoma and early diagnosis.
    Limaye AR; Cabrera R
    Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging in cirrhosis and hepatocellular carcinoma.
    Barr DC; Hussain HK
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of hepatocellular carcinoma.
    Onaya H; Itai Y
    Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):757-68. PubMed ID: 11149678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.
    Krinsky GA; Lee VS; Theise ND; Weinreb JC; Morgan GR; Diflo T; John D; Teperman LW; Goldenberg AS
    Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.